ArticleBMC cancer2026

Immune checkpoint inhibitor-related efficacy in non-small cell lung cancer: real-world incidence and management practices of 208 patients.

Yufang Lu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.